|
⚲
|
| Keyboard |
| Sunstone Life Science Ventures Fund II K/S
✚
|
|
|---|---|
| CIK # | 0001591179 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001591179] | |
| 4 | [0001591179] | |
| SC 13G | [0001591179] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Sunstone Life Science Ventures Fund II K/S | Orphazyme A/S | [2021-02-11] |
| Sunstone Life Science Ventures Fund II K/S | Egalet Corp | [2014-02-24] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sunstone Life Science Ventures Fund II K/S | |
| Zyla Life Sciences |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Buy | 133,333 | $12.00 | 1,599,996 |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 273,986 | $6.00 | 1,643,916 |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 202,658 | $6.00 | 1,215,948 |
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 416,812 | ||
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Conversion | 736,826 | ||
|
Zyla Life Sciences EGLT
Common Stock
|
2014-02-11 | Option exercise | 96,000 | $0.00 | |
|
Zyla Life Sciences EGLT
Series A-1 Preferred Stock · derivative
|
2014-02-11 | Conversion | 416,812 | $0.00 | |
|
Zyla Life Sciences EGLT
Series B Preferred Stock · derivative
|
2014-02-11 | Conversion | 736,826 | $0.00 | |
|
Zyla Life Sciences EGLT
Senior Convertible Debt · derivative
|
2014-02-11 | Conversion | $0.00 | ||
|
Zyla Life Sciences EGLT
Subordinated Convertible Debt · derivative
|
2014-02-11 | Conversion | $0.00 | ||
|
Zyla Life Sciences EGLT
Warrants · derivative
|
2014-02-11 | Option exercise | 96,000 | $0.00 |